KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 180 filers reported holding KARUNA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.45 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $420 | -1.4% | 2,482 | +26.4% | 0.03% | -5.9% |
| Q2 2023 | $426 | +8.7% | 1,963 | -9.0% | 0.03% | +17.2% |
| Q1 2023 | $392 | -6.9% | 2,157 | +0.7% | 0.03% | -17.1% |
| Q4 2022 | $421 | -99.9% | 2,143 | +12.0% | 0.04% | -12.5% |
| Q3 2022 | $431,000 | -21.1% | 1,914 | -55.7% | 0.04% | -18.4% |
| Q2 2022 | $546,000 | +65.0% | 4,316 | +65.6% | 0.05% | +345.5% |
| Q1 2022 | $331,000 | – | 2,607 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pivotal bioVenture Partners Investment Advisor LLC | 797,008 | $134,766,083 | 53.75% |
| Nan Fung Group Holdings Ltd | 225,688 | $38,161,584 | 30.90% |
| Sofinnova Investments, Inc. | 1,381,149 | $233,538,484 | 14.73% |
| First Light Asset Management, LLC | 303,137 | $51,257,435 | 4.87% |
| Altium Capital Management LP | 34,000 | $5,749,060 | 3.00% |
| DAFNA Capital Management LLC | 52,873 | $8,940,296 | 2.78% |
| Logos Global Management LP | 115,000 | $19,445,350 | 2.59% |
| GENERAL ATLANTIC, L.P. | 986,710 | $166,842,794 | 2.58% |
| MPM BioImpact LLC | 53,210 | $8,997,279 | 2.40% |
| Rock Springs Capital Management LP | 505,433 | $85,463,666 | 2.29% |